MedTrace Logo

Prevention of Postoperative Bleeding in Subcapital Femoral Fractures

NCT02150720 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 161

Last updated 2016-09-20

No results posted yet for this study

Summary

The main hypothesis of this clinical trial is that the use of intra-articular tranexamic acid and the fibrin glue plus usual hemostasis will reduce at least a 25% the postoperative blood loss with respect to usual hemostasis in patients undergoing subcapital femoral fractures.

Conditions

  • Hip Fracture
  • Blood Loss

Interventions

DRUG

Tranexamic Acid

1g intra-articular before closing the wound surgery

DRUG

Fibrin glue

5mL intra-articular before closing the wound surgery

PROCEDURE

Electrocauterization

Coagulation blood from vessels by means of a electrocautery.

Sponsors & Collaborators

  • Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

    lead OTHER

Principal Investigators

  • MJ Martínez-Zapata, MD, PhD · Iberoamerican Cochrane Centre. Research Institut Hospital de la Santa Creu i Sant Pau. IIB Sant Pau

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2015-04-30
Completion
2016-03-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02150720 on ClinicalTrials.gov